The products will be 'highly similar to' existing FDA-approved medications.

CVS Health to Produce Lower-Cost ‘Biosimilar’ Medicines

CVS Health is set to establish Cordavis, a subsidiary unit aimed at partnering with pharmaceutical companies to develop biosimilar products, which are essentially replicas of already approved drugs. The primary objective of this unit is to introduce FDA-approved biosimilar products to the U.S. market, potentially revolutionizing the way consumers purchase medications by fostering competition and reducing prices. This subsidiary does not reinvent the wheel with new drugs. All manufactured biosimilar products are very similar to an already approved biologic drug, but are tested and approved to ensure that they are…

Researchers from the University of Bath used turpentine to produce chemical precursors.

News

Researchers Transform Paper Industry Waste into Ibuprofen and Other Painkillers

Sanjay PatilJuly 10, 23health, Pharmaceutical, Science

When people think of the pharmaceutical industry, they usually don’t associate it with the production of life-saving drugs and environmental degradation. However, a study conducted in 2019 by The Conversation revealed that drug companies actually produce more carbon dioxide equivalents per million dollars than the automotive industry. The study found that the pharmaceutical market, although 28 percent smaller, is 13 percent more polluting than the automotive sector. In other words, it is crucial for drug companies to decrease their carbon emissions in order to protect the planet and its inhabitants.…